Skip to content
Verdiktum

Bioceltics has a chance to be the first Polish biotechnology company, listen, th...

A

📅 18.04.2026 · W poszukiwaniu polskiej Nokii czyli 10 kandydatów na po... · 👁️ 16

"Bioceltics has a chance to be the first Polish biotechnology company, listen, that will release its own innovative drug, a so-called first in the class, on the market. No one has succeeded so far." "Bioceltics ma szansę być pierwszą polską spółką, słuchajcie, biotechnologiczną, która wypuści własny innowacyjny lek, tak zwany first in the class, na rynek. Nikomu się do tej pory nie udało."
🌐 (Machine-translated — original in Polish) · oryginał w języku polskim
🔮 Forecast 🔬 Technology Short timeframe (under 1 year) AI Confidence: 90% Assertiveness: high Source on YouTube

Source (proof)

Plays from the quoted moment

Verification

Analysis generated with AI Pro
Available in the Pro plan Full AI analysis, sources, counterarguments Unlock Pro
🤖
AI-generated analysis: This result is an assessment by a language model, not an expert opinion or a legally binding verdict. Verify sources before making any decisions. Model: gemini-2.5-flash

For informational purposes only. Not investment, financial, legal or tax advice. Full disclaimer

AI is analyzing your argument…

Community Arguments (AI Feedback)

Log in to use this feature

Login

Transcript excerpt

Oryginał w języku Polskim Open on YouTube

To są leki, które mają leczyć takie bardzo kłopotliwe schorzenia piesków. Na początek psy wzięli na celownik właśnie twórcy Bioceltixu i to jest lek przede wszystkim pierwszy na takie zwyrodnieniowe zapalenie stawów u psów i drugi na tak zwany azs, czyli atopowe zapalenie skóry u psów. I to są leki innowacyjne, pierwsza tego rodzaju na świecie. I Bioceltics ma szansę być pierwszą polską spółką, słuchajcie, biotechnologiczną, która wypuści własny innowacyjny lek, tak zwany first in the class, na rynek. Nikomu się do tej pory nie udało. Mabion próbował, Celonfarma próbuje wciąż ze skateminą. To się przeciąga strasznie. Tak. Jedyną spółką, która w ogóle dopuściła taki lek ważny, no to jest Polfarma, ale to nie nie był ich lek innowacyjny, tylko tak zwany biopodobny, czyli po wygaśnięciu patentu oni mogli wypuścić taką podróbkę, nazwijmy to tak, czyli lek podobny, analogiczny i spr

Comments

No comments yet. Be the first!

Sign in to leave a comment.

Related claims by Albert Rokicki

Albert Rokicki Albert Rokicki 11.03.2026
Pending
"This great generational bull market will last somewhere until the mid-2040s, meaning we still have about 20 years of very strong growth in the Polish market. We will catch up to Western countries, we will catch up to France, Germany, Great Britain, and later also the United States in the development of the capital market in particular. "
translated PL · original
🔮 Forecast Economy 2045
Albert Rokicki Albert Rokicki 02.04.2026
Fulfilled
"The stock market sooner or later discounts, as they say, or anticipates an improvement in economic conditions or better profits that will appear not even next year, but for example in 2028, since we are recording this at the beginning of 2026, I am talking here about a very long-term game where you can buy cheap companies that no one notices or most assume that they will still have time to buy, that before the improvement occurs, there will still be many months of such lethargy, and often one can be mistaken, because the price often rebounds a year or even a year and a half before the improvement in results, because the best informed, they are already observing it, they are closest to the management board or even people around the management board, right, or insiders can officially buy. One should also observe how the company presidents behave, whether they are buying more, whether key managers are buying shares, because this can be a valuable signal for us that an improvement is on the horizon. "
translated PL · original
💬 Opinion Economy
Albert Rokicki Albert Rokicki 03.06.2026
Pending
"Firstly, foreign capital is flowing into Poland like never before, because we are the cheapest gateway to the reconstruction of Ukraine. Plus 30-50% on the largest companies. "
translated PL · original
🌐 Scenario Economy
Albert Rokicki Albert Rokicki 11.03.2026
~ Partially
"Poland has a huge future, in my opinion, both in terms of the capital market and economically, especially the capital market should do well. For example, Eleven Labs is considering a dual listing, both on the New York stock exchange and in Poland. Also, a defense company, WB Electronic, worth PLN 30 billion, will enter WIG20 practically automatically. Very good times are ahead of us. Simply put, good companies will enter the stock exchange, and weak ones will go into oblivion, so to speak. "
translated PL · original
🔮 Forecast Economy Medium timeframe